Zero layoffs across
two decades
of scale
Flag data anomalies before database lock
The Biometrics CRO
for the AI era.
20 years. Building biometrics at scale
three continents.
to private equity.
Acrosian is a single integrated biometrics CRO partner bringing together the four functions that have the greatest impact on clinical trial timelines and submission quality:
Clinical Data Management
Biostatistics
Statistical Programming
Medical Writing
One point of accountability.
One quality system. One audit trail.
AI changes the ratio of senior judgment to repetitive labor.
These outcomes have traditionally demanded headcount-driven delivery.
We designed Acrosian around AI from day one. There is no legacy delivery model to retrofit. There is no organizational complexity to overcome. There is the work done by the people best equipped to do it in the era we are now in.
Two decades ago, our founding team built a biometrics CRO on the leverage that the internet era made possible.
We scaled it into one of the industry’s largest independent biometrics CROs, with operations spanning three continents, and successfully exited to private equity.
We saw AI changing biometrics in fundamental ways, and we made a deliberate decision: rather than build on top of legacy systems designed for a different era, we chose to start fresh with an AI-augmented biometrics CRO built specifically for the future of clinical research. That restart is Acrosian.